Literature DB >> 11121863

Simian virus 40 is present in human lymphomas and normal blood.

H David1, S Mendoza, T Konishi, C W Miller.   

Abstract

Many independent studies have demonstrated Simian virus 40 (SV40) in normal and neoplastic human tissues. Clonal integration of virus in the DNA of several thyroid and bone tumors suggests a direct role for SV40 in some cancers. However, in most cases the role of SV40 remains unclear. This study determined the presence of SV40, by amplification followed by hybridization, in 266 normal and neoplastic blood and lymphoid samples. Amplification detected SV40 in 14% of non-autoimmune deficiency syndrome (AIDS) lymphomas, 28% of AIDS related lymphoma and 16% of peripheral blood lymphocytes from non-cancerous patients. No SV40 was detected in leukemia samples. Direct Southern blotting of SV40+ samples detected no virus, consistent with less than one viral genome in ten cells. Sequence analysis of SV40 in blood and lymphoid samples found sequences distinct from laboratory strains of SV40. The presence of limited quantities of SV40 in a small proportion of both normal and neoplastic tissues is suggestive of an adventitious presence with no apparent direct role in blood and lymphoid cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11121863     DOI: 10.1016/s0304-3835(00)00628-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Presence of simian virus 40 DNA sequences in egyptian patients with lymphoproliferative disorders.

Authors:  Waleed S Mohamed; Mohamed A Samra; Mohamed A Fawzy
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

2.  Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort.

Authors:  Valentina Paracchini; Seymour Garte; Paola Pedotti; Francesca Poli; Sara Frison; Emanuela Taioli
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 3.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines.

Authors:  Sophie Shaikh; Christine Skoczylas; Richard Longnecker; Kathleen Rundell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 5.  Simian virus 40 and its association with human lymphomas.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

6.  Detection of polyomavirus SV40 in tonsils from immunocompetent children.

Authors:  Niraj C Patel; Regis A Vilchez; Deanna E Killen; Preeti Zanwar; Vojtech Sroller; Karen W Eldin; Dolores López-Terrada; Janet S Butel
Journal:  J Clin Virol       Date:  2008-06-09       Impact factor: 3.168

7.  Detection and typing of BKV, JCV, and SV40 by multiplex nested polymerase chain reaction.

Authors:  Massimiliano Bergallo; Cristina Costa; Samuela Margio; Francesca Sidoti; Giuseppe P Segoloni; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

8.  Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas.

Authors:  Connie Wong; Regis A Vilchez; Jorge Quiroz; Ervin Adam; Janet S Butel
Journal:  J Infect       Date:  2012-08-30       Impact factor: 6.072

9.  Simian virus 40 sequences in human lymphoblastoid B-cell lines.

Authors:  Riccardo Dolcetti; Fernanda Martini; Michele Quaia; Annunziata Gloghini; Beatrice Vignocchi; Roberta Cariati; Marcella Martinelli; Antonino Carbone; Mauro Boiocchi; Mauro Tognon
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival.

Authors:  N A C S Wong; F Rae; M M Herriot; N J Mayer; D H Brewster; D J Harrison
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.